SOUV0010-Souvenaid-MCI-tile-v2-800x600

About Souvenaid

Souvenaid® is an evidence based medical drink supported by 20 years of research and proven to support memory function in patients with mild cognitive impairment and mild Alzheimer’s disease.

Learn more

Patient resources

Souvenaid® range

Memory-hub-Souvenaid-Liquid-Range
Souvenaid® liquid
Powered by Fortasyn Connect®, a unique combination of nutrients formulated to support the growth of brain connections. Available in 3 delicious flavors, Vanilla, Cappuccino, and Strawberry, in ready-to-drink single serve 125ml bottles.
Memory-hub-Souvenaid-Powder-Range
Souvenaid® Powder
Powered by Fortasyn Connect®, a unique combination of nutrients formulated to support the growth of brain connections. Available in 2 delicious flavors, Vanilla & Banana and Lemon & Orange, in a convenient travel & storage format.

Memory Expert resources

CMPA Patient Case Studies

APP 2022 Conference Lecture - Mild Cognitive Impairment, what pharmacists need to know.

In this lecture, recorded at the APP Conference in March 2022, Associate Professor Michael Woodward, Geriatrician & Director at Aged Care Research, Austin Health, shares his expert knowledge on Mild Cognitive Impairment.
Learn more
CMPA Clinical Papers

Early signs of Alzheimer’s disease

Alzheimer’s disease is a complex condition that often starts to develop decades before symptoms appear. In the early stages, specific regions in the brain, crucial for memory, are affected causing frequency and severity of memory lapses.
Learn more
Break through the burden of CMPA

The role of Souvenaid® in the management of patients with early Alzheimer’s disease.

Associate Professor Michael Woodward gives a 5 minute lecture on the evidence for the medical food Souvenaid® and its role in the management of patients with early Alzheimer’s disease including mild cognitive impairment.

Learn more
MCI causes cognitive changes that are serious enough to be noticed by the person affected and by family and friends.

Understanding Mild Cognitive Impairment (MCI)

MCI causes cognitive changes that are serious enough to be noticed by the person affected and by family and friends.1 It is estimated that people with MCI have a 3 to 5 times increased risk of developing dementia and yet it can be challenging to differentiate MCI from normal ageing.2

Learn more
Souvenaid can be funded as part of a Home Care Package.

Home Care Packages and Souvenaid®

Souvenaid® is included and can be funded as part of a patient Home Care Package if aligned with the patients identified needs and preferences and when prescribed by a treating healthcare professional. 

Download info

Inaugural MCI Masterclass 2021